Kronos Bio, Inc. Operating Expenses
Kronos Bio, Inc. reported Operating Expenses of $11.31 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-08.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2025-05-08
- Kronos Bio, Inc. operating expenses for the quarter ending 2025-03-31 was $11.31M, a 67.24% decline year-over-year.
- Kronos Bio, Inc. operating expenses for the quarter ending 2024-12-31 was $29.42M, a 1.52% decline year-over-year.
- Kronos Bio, Inc. operating expenses for the quarter ending 2024-09-30 was $18.09M, a 47.94% decline year-over-year.
- Kronos Bio, Inc. operating expenses for the quarter ending 2024-06-30 was $20.71M, a 39.14% decline year-over-year.
- Kronos Bio, Inc. operating expenses for fiscal 2024 was $102.73M, a 19.97% decline from fiscal 2023.
- Kronos Bio, Inc. operating expenses for fiscal 2023 was $128.37M, a 6.38% decline from fiscal 2022.
- Kronos Bio, Inc. operating expenses for fiscal 2022 was $137.12M, a 9.43% decline from fiscal 2021.
- Kronos Bio, Inc. operating expenses for fiscal 2021 was $151.40M, a 160.83% increase from fiscal 2020.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|
| 2025-03-31 | $11.31M 10-Q · filed 2025-05-08 | $40.73M derived: sum of 2 quarters · filed 2025-05-08 | $58.82M derived: sum of 3 quarters · filed 2025-05-08 | $79.53M derived: sum of 4 quarters · filed 2025-05-08 | |
| 2024-12-31 | $29.42M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $47.51M derived: sum of 2 quarters · filed 2025-03-18 | $68.22M derived: sum of 3 quarters · filed 2025-03-18 | $102.73M 10-K · filed 2025-03-18 | |
| 2024-09-30 | $18.09M 10-Q · filed 2024-11-13 | $38.80M derived: sum of 2 quarters · filed 2024-11-13 | $73.31M 10-Q · filed 2024-11-13 | $103.19M derived: sum of 4 quarters · filed 2025-05-08 | |
| 2024-06-30 | $20.71M 10-Q · filed 2024-08-08 | $55.23M 10-Q · filed 2024-08-08 | $85.10M derived: sum of 3 quarters · filed 2025-05-08 | $119.84M derived: sum of 4 quarters · filed 2025-05-08 | |
| 2024-03-31 | $34.51M 10-Q · filed 2025-05-08 | $64.39M derived: sum of 2 quarters · filed 2025-05-08 | $99.13M derived: sum of 3 quarters · filed 2025-05-08 | $133.16M derived: sum of 4 quarters · filed 2025-05-08 | |
| 2023-12-31 | $29.88M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $64.62M derived: sum of 2 quarters · filed 2025-03-18 | $98.65M derived: sum of 3 quarters · filed 2025-03-18 | $128.37M 10-K · filed 2025-03-18 | $128.12M 10-K · filed 2024-03-21 |
| 2023-09-30 | $34.74M 10-Q · filed 2024-11-13 | $68.77M derived: sum of 2 quarters · filed 2024-11-13 | $98.49M 10-Q · filed 2024-11-13 | $132.17M derived: sum of 4 quarters · filed 2024-11-13 | |
| 2023-06-30 | $34.03M 10-Q · filed 2024-08-08 | $63.75M 10-Q · filed 2024-08-08 | $97.43M derived: sum of 3 quarters · filed 2024-08-08 | $130.97M derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | $29.71M 10-Q · filed 2024-05-09 | $63.40M derived: sum of 2 quarters · filed 2024-05-09 | $96.93M derived: sum of 3 quarters · filed 2024-05-09 | $130.46M derived: sum of 4 quarters · filed 2024-05-09 | |
| 2022-12-31 | $33.68M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $67.22M derived: sum of 2 quarters · filed 2024-03-21 | $100.75M derived: sum of 3 quarters · filed 2024-03-21 | $137.12M 10-K · filed 2024-03-21 | |
| 2022-09-30 | $33.54M 10-Q · filed 2023-11-13 | $67.07M derived: sum of 2 quarters · filed 2023-11-13 | $103.43M 10-Q · filed 2023-11-13 | $165.84M derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | $33.53M 10-Q · filed 2023-08-08 | $69.89M 10-Q · filed 2023-08-08 | $132.30M derived: sum of 3 quarters · filed 2023-08-08 | $165.97M derived: sum of 4 quarters · filed 2023-08-08 | |
| 2022-03-31 | $36.37M 10-Q · filed 2023-05-10 | $98.77M derived: sum of 2 quarters · filed 2023-05-10 | $132.44M derived: sum of 3 quarters · filed 2023-05-10 | $161.59M derived: sum of 4 quarters · filed 2023-05-10 | |
| 2021-12-31 | $62.41M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $96.08M derived: sum of 2 quarters · filed 2023-03-15 | $125.22M derived: sum of 3 quarters · filed 2023-03-15 | $151.40M 10-K · filed 2023-03-15 | |
| 2021-09-30 | $33.67M 10-Q · filed 2022-11-08 | $62.81M derived: sum of 2 quarters · filed 2022-11-08 | $88.99M 10-Q · filed 2022-11-08 | $110.08M derived: sum of 4 quarters · filed 2022-11-08 | |
| 2021-06-30 | $29.14M 10-Q · filed 2022-08-04 | $55.32M 10-Q · filed 2022-08-04 | $76.41M derived: sum of 3 quarters · filed 2022-08-04 | $97.22M derived: sum of 4 quarters · filed 2022-08-04 | |
| 2021-03-31 | $26.18M 10-Q · filed 2022-05-04 | $47.27M derived: sum of 2 quarters · filed 2022-05-04 | $68.08M derived: sum of 3 quarters · filed 2022-05-04 | $76.87M derived: sum of 4 quarters · filed 2022-05-04 | |
| 2020-12-31 | $21.09M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $41.90M derived: sum of 2 quarters · filed 2022-02-24 | $50.70M derived: sum of 3 quarters · filed 2022-02-24 | $58.04M 10-K · filed 2022-02-24 | |
| 2020-09-30 | $20.81M 10-Q · filed 2021-11-09 | $29.61M derived: sum of 2 quarters · filed 2021-11-09 | $36.96M 10-Q · filed 2021-11-09 | $42.81M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-06-30 | $8.80M 10-Q · filed 2021-08-12 | $16.15M 10-Q · filed 2021-08-12 | $22.00M derived: sum of 3 quarters · filed 2022-02-24 | $26.33M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-03-31 | $7.35M 10-Q · filed 2021-05-11 | $13.21M derived: sum of 2 quarters · filed 2022-02-24 | $17.53M derived: sum of 3 quarters · filed 2022-02-24 | ||
| 2019-12-31 | $5.86M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $10.18M derived: sum of 2 quarters · filed 2022-02-24 | $16.82M 10-K · filed 2022-02-24 | ||
| 2019-09-30 | $4.32M 10-Q · filed 2020-11-18 | $10.96M 10-Q · filed 2020-11-18 | |||
| 2018-12-31 | $6.64M 10-K · filed 2021-03-23 |